Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
UPDATE -- Figure brings $YLDS to Solana, unlocking real RWA utility for DeFi
-
TWG Announces Closing of $5.04 million Public Offering
-
Ovanti Teases US Launch of Flote: A Credit Score Agnostic Alternative to Buy Now Pay Later
-
Gran Tierra Energy Inc. Announces 2026 Guidance and Operations Update
-
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
-
D S Simon Media Launches the AI-Powered Broadcast Media Tour
-
BitMart Reshapes the Copytrading Revenue Model: Introducing AUM-based Management Fees, Enabling Traders to Operate Like Fund Managers
-
GlobalFoundries Appoints Sam Franklin as Chief Financial Officer
-
NOV Announces Sale of Advanced Nuclear Development Company Shepherd Power to Natura Resources in Stock for Stock Transaction
-
Statement from Beneficient Regarding the Passing of Thomas O. Hicks
-
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
-
Transcontinental Inc. Announces Results for the Fourth Quarter and Fiscal Year 2025
-
Major Drilling Announces Record Quarterly Revenue for its Second Quarter 2026
-
SPAR Group, Inc. Appoints Steven Hennen as New Chief Financial Officer
-
Univest Securities, LLC Announces Closing of $5.04 Million Public Offering for Its Client Top Wealth Group Holding Limited (NASDAQ: TWG)
-
Bakkt Files Post-Effective Amendments to Form S-3 Registration Statements Following Corporate Reorganization
-
Gemini Receives US License for Prediction Markets
-
Crinetics Pharmaceuticals Announces December 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Serve Robotics Expands to D.C. Area Bringing Autonomous Delivery to the City of Alexandria, Va.
-
Host Hotels & Resorts Announces Fourth Quarter 2025 Earnings Call to be Held on February 19, 2026
-
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
-
Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program
-
Daedalus Special Acquisition Corp. Announces Closing of Upsized $250 Million Initial Public Offering
-
ABITS Group maintains growth momentum in its third quarter of 2025
-
Grazing and Gifting: Sweet Solutions for the Holiday Rush
-
Oil-Dri’s Board of Directors Declares a 14% Increase in Quarterly Dividends
-
Sol Sister Sport Announces Functional, Sun-Protective Activewear Designed for the Growing Pickleball Community
-
DLH Reports Fiscal 2025 Fourth Quarter Results
-
AOI Receives First Volume Order of 800G Data Center Transceivers from Major Hyperscale Customer
-
Ryman Hospitality Properties, Inc. Announces Fourth Quarter 2025 Earnings Conference Call – Tuesday, February 24, 2026, 10 a.m. ET
-
FutureFuel Corp. Declares First Quarter 2026 Cash Dividend; Extends Share Repurchase Program
-
Balchem Corporation Announces Dividend
-
Intuitive Announces Expanded Indications for da Vinci SP
-
Atlanticus Refinances Securitization Facility
-
Clearmind Medicine Announces 1-for-40 Reverse Share Split
-
BRT Apartments Corp. Announces Quarterly Dividend
-
Sunrise New Energy Signs Supply Agreement to Deliver 246 Tons in December, With an Annual Forecast of 3,000 Tons for Telecom Tower Backup Power Applications
-
Bimini Capital Management, Inc. Amends and Extends Stockholder Rights Plan
-
AMSC Accelerates the Business, Expands Product Portfolio, and Enters Brazil with Comtrafo Acquisition
-
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports Third Quarter Results
-
Nayax Announces the Completion of a Notes and Warrants Offering in Israel
-
GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”)
-
T1 Energy Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2030 and Common Stock
-
Perimeter Solutions Announces Agreement to Acquire MMT for $685 Million
-
Aardvark Therapeutics Announces First Patient Dosed in Australia in HERO Phase 3 Trial for Prader-Willi Syndrome
-
BBOT Announces Late-Breaking Preclinical Data on BBO-10203, a First-in-Class RAS:PI3Kα Breaker, at the San Antonio Breast Cancer Symposium (SABCS)
-
Robinhood Markets, Inc. Reports November 2025 Operating Data
-
Dynagas LNG Partners LP Announces New $10 Million Common Unit Repurchase Program
-
Credit Acceptance Honored for the 11th Time as a Best Place to Work in IT by Computerworld
-
Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025
